Finance

Lists
Why is YDES down 5,94%?
Dive Deeper
YDES:NASDAQ
YD Bio Ltd
USD 6,33
-5,94%
(-0,40) 1D
12 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for YDES...
Open
USD 7,01
High
USD 7,13
Low
USD 6,10
Mkt. cap
448,44 m
Avg. vol.
566,79 k
Volume
138,11 k
52-wk high
USD 22,00
52-wk low
USD 1,70
EPS
-USD 0,00
Beta
-0,13
Shares outstanding
70,84 m
No. of employees
14
Open
USD 7,01
High
USD 7,13
Low
USD 6,10
Mkt. cap
448,44 m
Avg. vol.
566,79 k
Volume
138,11 k
52-wk high
USD 22,00
52-wk low
USD 1,70
EPS
-USD 0,00
Beta
-0,13
Shares outstanding
70,84 m
No. of employees
14
News stories
From web sources and news partners
About YD Bio Ltd
CEO-
Employees14
Founded2013
Headquarters-
SectorAerospace and Defense
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Mrt. 2026
Jun. 2026
Revenue
102,00 k
102,00 k
423,25 k
423,25 k
Cost of goods sold
67,61 k
67,61 k
289,14 k
289,14 k
Cost of revenue
67,61 k
67,61 k
289,14 k
289,14 k
Research and development expenses
395,73 k
395,73 k
556,88 k
556,88 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
613,53 k
613,53 k
1,19 m
1,19 m
Operating expense
1,01 m
1,01 m
1,75 m
1,75 m
Total operating expenses
1,08 m
1,08 m
2,04 m
2,04 m
Operating income
-976,92 k
-976,92 k
-1,62 m
-1,62 m
Other non operating income
8,65 k
8,65 k
4,94 m
4,94 m
EBT including unusual items
-959,04 k
-959,04 k
3,35 m
3,35 m
EBT excluding unusual items
-959,04 k
-959,04 k
3,35 m
3,35 m
Income tax expense
-754,00
-753,00
-
-
Effective tax rate
0,08%
0,08%
-
-
Other operating expenses
-
-
-
-
Net income
-958,29 k
-958,29 k
3,35 m
3,35 m
Net profit margin
-939,46%
-939,47%
791,55%
791,55%
Earnings per share
-
-
-
-
Interest and investment income
9,22 k
9,22 k
26,35 k
26,35 k
Interest expense
-
-
-
-
Net interest expenses
9,22 k
9,22 k
26,35 k
26,35 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-925,32 k
-925,32 k
-1,57 m
-1,57 m
Gain or loss from assets sale
-
-
1,96 k
1,96 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme